Received Jun 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | Y015022 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z004454 | — |
No symptomatic events were reported. No additional AE; MMR II and VARIVAX were administered to a patient when they did not need to receive it.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent and concomitant therapies were not reported. On 19-JUN-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) injection, lot #Z004454 [which has been verified to be valid lot number for Varicella Virus Vaccine Live (Oka-Merck)], expiration date reported and upon internal validation establish as 13-FEB-2027 and with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) injection, lot #Y015022 [which has been verified to be valid lot number for Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live], expiration date reported and upon internal validation establish as 05-SEP-2026. The vaccines were reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported) and were administered for prophylaxis (strength, dosage, route and anatomical site of administration were not reported). It was reported that the vaccines were administered although the patient did not need to receive them (Wrong product administered). No symptomatic events were reported (No adverse event).
Sterile diluent